These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7879084)

  • 61. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 62. Simultaneous evaluation of nitric oxide synthesis and tissue oxygenation in rat liver allograft rejection using near-infrared spectroscopy.
    Ohdan H; Fukuda Y; Suzuki S; Amemiya H; Dohi K
    Transplantation; 1995 Sep; 60(6):530-5. PubMed ID: 7570946
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection.
    Worrall NK; Misko TP; Sullivan PM; Hui JJ; Ferguson TB
    Ann Thorac Surg; 1996 Aug; 62(2):378-85. PubMed ID: 8694595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation.
    Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115
    [No Abstract]   [Full Text] [Related]  

  • 67. Local immunosuppression with budesonide after liver transplantation in the rat: a preliminary histomorphological analysis.
    Weber T; Kalbhenn T; Herrmann G; Hanisch E
    Transplantation; 1997 Sep; 64(5):705-8. PubMed ID: 9311706
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of local administration of 15-deoxyspergualin on liver allografts in the rat: preliminary report].
    Yano K; Fukuda Y; Sumimoto K; Sumimoto R; Kimura A; Ito H; Dohi K
    Nihon Geka Gakkai Zasshi; 1992 Aug; 93(8):866. PubMed ID: 1435714
    [No Abstract]   [Full Text] [Related]  

  • 69. The immunosuppressive effect of 5-lipoxygenase inhibitor on liver allotransplantation in rats.
    Iyobe T; Izumi R; Shimizu K
    Transplantation; 1993 Sep; 56(3):518-23. PubMed ID: 8212143
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chronic allograft rejection.
    Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen-Sokolowski A; Koskinen P; Ustinov J; Lautenschlager I; Taskinen E
    Immunol Rev; 1993 Aug; 134():33-81. PubMed ID: 8225374
    [No Abstract]   [Full Text] [Related]  

  • 71. Histopathology of hepatic allograft rejection after living-related liver transplantation.
    Sageshima J; Fuchinoue S; Hashimoto E; Koike T; Abe M; Nakajima I; Tanaka K; Agishi T
    Transplant Proc; 1998 Nov; 30(7):3214-5. PubMed ID: 9838421
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of leukotriene B(4) receptor antagonist (ONO4057) on hepatic allografting in rats.
    Tanaka M; Tamaki T; Konoeda Y; Uchida Y; Kaizu T; Kawamura A
    Transplant Proc; 2000 Nov; 32(7):2340. PubMed ID: 11120191
    [No Abstract]   [Full Text] [Related]  

  • 73. Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature.
    Nakanishi C; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Miyagi S; Takeda I; Hukushima K; Aiso T; Sato A; Fujimori K; Satomi S
    Tohoku J Exp Med; 2007 Feb; 211(2):195-200. PubMed ID: 17287604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium.
    Cramer DV; Knoop M; Chapman FA; Wa GD; Jaffee BD; Makowka L
    Transplantation; 1992 Oct; 54(4):752-3. PubMed ID: 1412774
    [No Abstract]   [Full Text] [Related]  

  • 75. Activation of Fas and perforin pathways in rat liver allograft rejection.
    Li XK; Kita Y; Tamura A; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1998 Feb; 30(1):19-21. PubMed ID: 9474944
    [No Abstract]   [Full Text] [Related]  

  • 76. Frequent occurrence of hepatocytic apoptosis in acute rejection of the grafted rat liver.
    Hayashi A; Ito H; Shomori K; Ohdan H; Yano K; Asahara T
    Pathol Int; 1997 Aug; 47(8):518-24. PubMed ID: 9293531
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CMV causes bile duct destruction and arterial lesions in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Mäkisalo H; Bruggeman C; Lautenschlager I
    Transplant Proc; 1997; 29(1-2):796-7. PubMed ID: 9123529
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats.
    Hossain MA; Wakabayashi H; Goda F; Kobayashi S; Maeba T; Maeta H
    Transplant Proc; 2000 Nov; 32(7):2021-3. PubMed ID: 11120048
    [No Abstract]   [Full Text] [Related]  

  • 79. Deoxyspergualin for liver graft rejection.
    Groth CG; Ohlman S; Ericzon BG; Barkholt L; Reinholt FP
    Lancet; 1990 Sep; 336(8715):626. PubMed ID: 1975391
    [No Abstract]   [Full Text] [Related]  

  • 80. HIV-1 Nef protein prolonged recipient survival in rat liver allografting.
    Adachi K; Li X; Kimura H; Amemiya H; Suzuki S
    Transplant Proc; 2001; 33(1-2):284. PubMed ID: 11266821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.